- Home
- SPRU vs ACRV Comparison
SPRU vs ACRV Comparison
Compare SPRU & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRU
- ACRV
- Stock Information
- Founded
- SPRU 2008
- ACRV 2018
- Country
- SPRU United States
- ACRV United States
- Employees
- SPRU N/A
- ACRV N/A
- Industry
- SPRU Auto Parts:O.E.M.
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- SPRU Consumer Discretionary
- ACRV Health Care
- Exchange
- SPRU Nasdaq
- ACRV Nasdaq
- Market Cap
- SPRU 34.2M
- ACRV 36.1M
- IPO Year
- SPRU N/A
- ACRV 2022
- Fundamental
- Price
- SPRU $2.01
- ACRV $1.09
- Analyst Decision
- SPRU
- ACRV Buy
- Analyst Count
- SPRU 0
- ACRV 7
- Target Price
- SPRU N/A
- ACRV $17.60
- AVG Volume (30 Days)
- SPRU 128.8K
- ACRV 728.6K
- Earning Date
- SPRU 05-14-2025
- ACRV 05-14-2025
- Dividend Yield
- SPRU N/A
- ACRV N/A
- EPS Growth
- SPRU N/A
- ACRV N/A
- EPS
- SPRU N/A
- ACRV N/A
- Revenue
- SPRU $87,638,000.00
- ACRV N/A
- Revenue This Year
- SPRU $2.12
- ACRV N/A
- Revenue Next Year
- SPRU N/A
- ACRV N/A
- P/E Ratio
- SPRU N/A
- ACRV N/A
- Revenue Growth
- SPRU 9.48
- ACRV N/A
- 52 Week Low
- SPRU $1.42
- ACRV $1.05
- 52 Week High
- SPRU $3.94
- ACRV $10.16
- Technical
- Relative Strength Index (RSI)
- SPRU 53.74
- ACRV 34.87
- Support Level
- SPRU $1.92
- ACRV $1.06
- Resistance Level
- SPRU $2.09
- ACRV $1.19
- Average True Range (ATR)
- SPRU 0.19
- ACRV 0.09
- MACD
- SPRU 0.03
- ACRV 0.05
- Stochastic Oscillator
- SPRU 75.54
- ACRV 21.57
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.